📱 Now on iPhone — live scores, valuations & alerts on the go
Park Ha Biological Technology Co., Ltd. (BYAH)
Materials
Inconclusive
inconclusive
mixed
$2.21
Updated: 2026-10-25
As of October 25, 2026, TradeApes rates Park Ha Biological Technology Co., Ltd. (BYAH) 58 out of 100 (Mixed); valuation verdict: Inconclusive.
Financial Strength
55
Mixed
Relative Value
65
Fair value
Capital Allocation
50
Mixed
Risk Management
80
Strong
BYAH is a type of company our standard valuation methods don't fit, so we don't publish a fair value for it.
Key Findings
What's working
-
+
High FCF yield — above 7%, strong cash return relative to price paid
-
+
Strong liquidity — current assets more than 2× current liabilities
AI-written analysis
The full Park Ha Biological Technology Co., Ltd. (BYAH) analysis
Writing the BYAH analysis…0s
Save your watchlist
Create a free account to keep tracking these stocks with full analysis.
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.